Key result
Elevated complement C3 linked to ~423% higher NAFLD risk independent of obesity and metabolic syndrome.
Why the study?
Are serum complement C3 levels associated with the prevalence and severity of NAFLD in adults?
Cross-Sectional (n=7,540)
No
Are serum complement C3 levels associated with the prevalence and severity of NAFLD in adults?
Serum complement C3 levels are independently associated with the prevalence and severity of NAFLD, even in lean and metabolic syndrome-free individuals.
Answers are grounded in this paper and cite their sources.
C3 may stratify NAFLD risk beyond metabolic factors; leaves open causality and need for prospective validation.
Serum complement C3 levels are closely associated with obesity and related metabolic disorders. This study aimed to investigate the association between serum complement C3 levels with non-alcoholic fatty liver disease (NAFLD). A cross-sectional study was performed among adults who took their annual health examinations at Zhenhai Lianhua Hospital, Ningbo, China during 2014. We included 7540 participants (5069 men and 2471 women) in this study. NAFLD patients had higher serum complement C3 levels (P < 0.001), and these levels were positively associated with both NAFLD prevalence and severity (P < 0.001). The above association remains true among lean and metabolic syndrome-free participants. Multivariable regression analysis showed that serum complement C3 was independently associated with risk for NAFLD (OR = 5.231; 95% CI: 3.169-8.635). Serum complement C3 level is positively associated with prevalence and severity of NAFLD, and this association is independent of obesity and metabolic syndrome.
No takes yet. Share an insight, caveat, or question.
Xu et al. (2016) conducted a cross-sectional in Nonalcoholic fatty liver disease (NAFLD) (n=7,540). Serum complement C3 levels vs. Lower serum complement C3 levels was evaluated on Presence of NAFLD (OR 5.231, 95% CI 3.169-8.635, p=<0.001). Elevated serum complement C3 levels were independently associated with an increased risk of nonalcoholic fatty liver disease, independent of obesity and metabolic syndrome.
Synapse has enriched 10 related papers. Consider them for comparative context: